Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Isn't a NR---to be put out before a---
View:
Post by Impalaman on Sep 21, 2022 8:49am

Isn't a NR---to be put out before a---

PP is announced----is this not illegal.
Comment by skys1 on Sep 21, 2022 10:16am
Impalaman, Ask them where and when this supposed PP was announced, or occured.
Comment by robertshaw on Sep 21, 2022 11:47am
Hi, skys1. You got a PM message.
Comment by CAinPlap on Sep 21, 2022 12:04pm
Why not share with the board if you are discussing the PP?
Comment by Rumpl3StiltSkin on Sep 21, 2022 10:45am
Impala, who is saying that there has been a PP? Or are you asking this question? Yes, it would be illegal not to announce it. I don't think they need a PP quite yet..
Comment by Impalaman on Sep 21, 2022 12:54pm
Rump---Yes--I'm ask that question--Iv'e never heard of a PP not announced as a NR--from the company--or is it more (bullpuky) from members of this board?
Comment by Rumpl3StiltSkin on Sep 21, 2022 2:26pm
I think I remeber one investor here, who attended the last AGM, said that they were going to need money in ~ 6 months. Yet they thought they could raise their company profile prior to that, and work out a JV/etc. Well, It is just bullpuky for anyone from this board to speculate about a PP right now. It is still months away before they would need to consider that.
Comment by Rumpl3StiltSkin on Sep 21, 2022 2:32pm
Impala, I just was lookin' at ceo.ca. I think someone over there might be trying to pull a 'fast' one. ;-)
Comment by FGPstock on Sep 21, 2022 4:38pm
Rumpy, I don't think anyone is trying to pull a fast one. The company did mention they may need additional funds, but hope to raise at a higher price. I also think you are correct that it was someone that attended the AGM and heard it there. Can't recall who. To answer a few posters questions, a PP would not be publicly announced until after the price has been set and funds are secured, a ...more  
Comment by Rumpl3StiltSkin on Sep 21, 2022 10:44pm
FGP, Did you checkout the discussion over on ceo.ca? It is interesting.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250